Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

about

Serum circulating cell free DNA as potential diagnostic and prognostic biomarker in non small cell lung cancer.Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer

P2860

Q55439402-028F0F76-48CF-4188-8DAD-E4EDD6E3B381 Q58725269-14AC6A12-C730-43FE-B913-B7CD44C287B9

P2860

Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

Item

http://www.wikidata.org/entity/Q41162179

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

@en

type

Item

label

Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

@en

prefLabel

Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

@en

P1476

Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

@en

P2093

Binliang Liu

http://www.w3.org/2001/XMLSchema#string

Fei Ma

http://www.w3.org/2001/XMLSchema#string

Xiuwen Guan

http://www.w3.org/2001/XMLSchema#string

Zongbi Yi

http://www.w3.org/2001/XMLSchema#string

P2860

"Liquid biopsy"-ctDNA detection with great potential and challenges

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

Circulating DNA: diagnostic tool and predictive marker for overall survival of NSCLC patients

The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer.

Multiple marker detection in peripheral blood for NSCLC diagnosis

Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology

A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers.

Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.

Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy.

Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.

P304

167-172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2017.1301

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28781780

http://www.w3.org/2001/XMLSchema#string

P932

5532691

http://www.w3.org/2001/XMLSchema#string

Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

about

P2860

P2860

Plasma cell-free DNA and survival in non-small-cell lung cancer: A meta-analysis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932